Planta Med 2021; 87(04): 336-346
DOI: 10.1055/a-1270-7606
Pharmacokinetic Investigations
Original Papers

Enhanced Oral Bioavailability and Improved Biological Activities of a Quercetin/Resveratrol Combination Using a Liquid Self-Microemulsifying Drug Delivery System

1   Faculty of Traditional Thai Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
,
Subhaphorn Wanna
1   Faculty of Traditional Thai Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
,
Surasak Limsuwan
1   Faculty of Traditional Thai Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
,
Sasitorn Chusri
1   Faculty of Traditional Thai Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
,
Kamonthip Wiwattanawongsa
2   Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand
,
Ruedeekorn Wiwattanapatapee
3   Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand
› Author Affiliations
Supported by: Annual Income Budget of Prince of Songkla University 2018 TTM610706S, Fiscal year 2018

Abstract

Both quercetin and resveratrol are promising plant-derived compounds with various well-described biological activities; however, they are categorized as having low aqueous solubility and labile natural compounds. The purpose of the present study was to propose a drug delivery system to enhance the oral bioavailability of combined quercetin and resveratrol. The suitable self-microemulsifying formulation containing quercetin together with resveratrol comprised 100 mg Capryol 90, 700 mg Cremophor EL, 200 mg Labrasol, 20 mg quercetin, and 20 mg resveratrol, which gave a particle size of 16.91 ± 0.08 nm and was stable under both intermediate and accelerated storage conditions for 12 months. The percentages of release for quercetin and resveratrol in the self-microemulsifying formulation were 75.88 ± 1.44 and 86.32 ± 2.32%, respectively, at 30 min. In rats, an in vivo pharmacokinetics study revealed that the area under the curve of the self-microemulsifying formulation containing quercetin and resveratrol increased approximately ninefold for quercetin and threefold for resveratrol compared with the unformulated compounds. Moreover, the self-microemulsifying formulation containing quercetin and resveratrol slightly enhanced the in vitro antioxidant and cytotoxic effects on AGS, Caco-2, and HT-29 cells. These findings demonstrate that the self-microemulsifying formulation containing quercetin and resveratrol could successfully enhance the oral bioavailability of the combination of quercetin and resveratrol without interfering with their biological activities. These results provide valuable information for more in-depth research into the utilization of combined quercetin and resveratrol.

Supporting Information



Publication History

Received: 06 June 2020

Accepted after revision: 16 September 2020

Article published online:
11 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2009; 2: 270-278
  • 2 Duranti G, Ceci R, Patrizio F, Sgro P, Di Luigi L, Sabatini S, Felici F, Bazzucchi I. Chronic consumption of quercetin reduces erythrocytes oxidative damage: Evaluation at resting and after eccentric exercise in humans. Nutr Res 2018; 50: 73-81
  • 3 Khorshidi M, Moini A, Alipoor E, Rezvan N, Gorgani-Firuzjaee S, Yaseri M, Hosseinzadeh-Attar MJ. The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome. Phytother Res 2018; 32: 2282-2289
  • 4 Singh AP, Singh R, Verma SS, Rai V, Kaschula CH, Maiti P, Gupta SC. Health benefits of resveratrol: Evidence from clinical studies. Med Res Rev 2019; 39: 1851-1891
  • 5 Arias N, Macarulla MT, Aguirre L, Milton I, Portillo MP. The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue. Eur J Nutr 2016; 55: 341-348
  • 6 Intagliata S, Modica MN, Santagati LM, Montenegro L. Strategies to improve resveratrol systemic and topical bioavailability: an update. Antioxidants 2019; 8: 1-33
  • 7 Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C, Pezzi V. Progress to improve oral bioavailability and beneficial effects of resveratrol. Int J Mol Sci 2019; 20: 1-27
  • 8 Rani S, Rana R, Saraogi GK, Kumar V, Gupta U. Self-emulsifying oral lipid drug delivery systems: advances and challenges. AAPS PharmSciTech 2019; 20: 129
  • 9 Dokania S, Joshi AK. Self-Microemulsifying Drug Delivery System (SMEDDS)–challenges and road ahead. Drug Deliv 2015; 22: 675-690
  • 10 Patel MH, Mundada VP, Sawant KK. Novel drug delivery approach via self-microemulsifying drug delivery system for enhancing oral bioavailability of asenapine maleate: optimization, characterization, cell uptake, and in vivo pharmacokinetic studies. AAPS PharmSciTech 2019; 20: 44
  • 11 Zhang L, Zhang L, Zhang M, Pang Y, Li Z, Zhao A, Feng J. Self-emulsifying drug delivery system and the applications in herbal drugs. Drug Deliv 2015; 22: 475-486
  • 12 Yen CC, Chang CW, Hsu MC, Wu YT. Self-nanoemulsifying drug delivery system for resveratrol: enhanced oral bioavailability and reduced physical fatigue in rats. Int J Mol Sci 2017; 18: E1853
  • 13 Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 2010; 76: 475-485
  • 14 Jaisamut P, Wiwattanawongsa K, Wiwattanapatapee R. A novel self-microemulsifying system for the simultaneous delivery and enhanced oral absorption of curcumin and resveratrol. Planta Med 2017; 83: 461-467
  • 15 Weerapol Y, Limmatvapirat S, Nunthanid J, Sriamornsak P. Self-nanoemulsifying drug delivery system of nifedipine: impact of hydrophilic-lipophilic balance and molecular structure of mixed surfactants. AAPS PharmSciTech 2014; 15: 456-564
  • 16 Czajkowska-Kosnik A, Szekalska M, Amelian A, Szymanska E, Winnicka K. Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin. Molecules 2015; 20: 21010-21022
  • 17 Nikolakakis I, Partheniadis I. Self-emulsifying granules and pellets: composition and formation mechanisms for instant or controlled release. Pharmaceutics 2017; 9: 50
  • 18 Qian J, Meng H, Xin L, Xia M, Shen H, Li G, Xie Y. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation. Colloids Surf B Biointerfaces 2017; 160: 101-109
  • 19 Rao MRP, Aghav S, Sukre G, Kumar M. Determination of required HLB of Capryol 90. J Dispers Sci Technol 2014; 35: 161-167
  • 20 Shono Y, Nishihara H, Matsuda Y, Furukawa S, Okada N, Fujita T, Yamamoto A. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J Pharm Sci 2004; 93: 877-885
  • 21 Akhtar N, Ahad A, Khar RK, Jaggi M, Aqil M, Iqbal Z, Ahmad FL, Talegaonkar S. The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opin Ther Pat 2011; 21: 561-576
  • 22 Shen Y, Lu Y, Jv M, Hu J, Li Q, Tu J. Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats. Drug Dev Ind Pharm 2011; 37: 1415-1421
  • 23 Ghassemi S, Haeri A, Shahhosseini S, Dadashzadeh S. Labrasol-enriched nanoliposomal formulation: novel approach to improve oral absorption of water-insoluble drug, carvedilol. AAPS PharmSciTech 2018; 19: 2961-2970
  • 24 Liu C, Lv L, Guo W, Mo L, Huang Y, Li G, Huang X. Self-nanoemulsifying drug delivery system of tetrandrine for improved bioavailability: physicochemical characterization and pharmacokinetic study. Biomed Res Int 2018; 2018: 6763057
  • 25 Chanburee S, Tiyaboonchai W. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers. J Biomed Mater Res B Appl Biomater 2018; 106: 734-741
  • 26 Wu L, Qiao Y, Wang L, Guo J, Wang G, He W, Yin L, Zhao J. A Self-Microemulsifying Drug Delivery System (SMEDDS) for a novel medicative compound against depression: a preparation and bioavailability study in rats. AAPS PharmSciTech 2015; 16: 1051-1058
  • 27 Tang H, Xiang S, Li X, Zhou J, Kuang C. Preparation and in vitro performance evaluation of resveratrol for oral self-microemulsion. PLoS One 2019; 14: e0214544
  • 28 Sermkaew N, Plyduang T. Self-microemulsifying drug delivery systems of Moringa oleifera extract for enhanced dissolution of kaempferol and quercetin. Acta Pharm 2020; 70: 77-88
  • 29 Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 2019; 18: 57
  • 30 Chen Y, Zhang H, Yang J, Sun H. Improved antioxidant capacity of optimization of a self-microemulsifying drug delivery system for resveratrol. Molecules 2015; 20: 21167-21177
  • 31 Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2008; 355: 269-276
  • 32 Mekjaruskul C, Yang YT, Leed MG, Sadgrove MP, Jay M, Sripanidkulchai B. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-beta-cyclodextrin. Int J Pharm 2013; 445: 1-11
  • 33 Li W, Yi S, Wang Z, Chen S, Xin S, Xie J, Zhao C. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies. Int J Pharm 2011; 420: 161-171
  • 34 Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z, Zheng Y. Self-Nanoemulsifying Drug Delivery System (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm 2010; 383: 170-177
  • 35 Shen Q, Li X, Yuan D, Jia W. Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system. Chem Pharm Bull 2010; 58: 639-643
  • 36 LaGrow AP, Ingham B, Toney MF, Tilley RD. Effect of surfactant concentration and aggregation on the growth kinetics of nickel nanoparticles. J Phys Chem C 2013; 117: 16709-16718
  • 37 Gursoy RN, Benita S. Self-Emulsifying Drug Delivery Systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58: 173-182
  • 38 Lu JL, Wang JC, Zhao SX, Liu XY, Zhao H, Zhang X, Zhou SF, Zhang Q. Self-Microemulsifying Drug Delivery System (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. Eur J Pharm Biopharm 2008; 69: 899-907
  • 39 Li X, Yuan Q, Huang Y, Zhou Y, Liu Y. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech 2010; 11: 672-678
  • 40 Saah S, Kaewkroek K, Wiwattanapatapee R. Cytotoxic effect of surfactants used in Self-Microemulsifying Drug Delivery Systems (SMEDDS) on normal and cancer gastrointestinal cell lines. Lat Am J Pharm 2018; 37: 2244-2253
  • 41 Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G, Nikitovic D, Anisimov NY, Spandidos DA, Tsatsakis AM, Rezaee R. Anticancer and apoptosisinducing effects of quercetin in vitro and in vivo . Oncol Rep 2017; 38: 819-828
  • 42 Atashpour S, Fouladdel S, Movahhed TK, Barzegar E, Ghahremani MH, Ostad SN, Azizi E. Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin. Iran J Basic Med Sci 2015; 18: 635-643
  • 43 Del Follo-Martinez A, Banerjee N, Li X, Safe S, Mertens-Talcott S. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr Cancer 2013; 65: 494-504
  • 44 Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 2005; 218: 141-151
  • 45 Yang Z, Wang Y, Cheng J, Shan B, Wang Y, Wang R, Hou L. Solid self-microemulsifying drug delivery system of Sophoraflavanone G: Prescription optimization and pharmacokinetic evaluation. Eur J Pharm Sci 2019; 136: 104953
  • 46 The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Stability Testing Guidelines: Stability Testing of new Drug Substances and Products. London: ICH Steering Committee; 2003: 16-31
  • 47 The United States Pharmacopeia (USP). 30th National Formulary, 25th edition. Rockville, MD: The United States Pharmacopeia Convention; 2013: 361-398
  • 48 Dudonne S, Vitrac X, Coutiere P, Woillez M, Merillon JM. Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC assays. J Agric Food Chem 2009; 57: 1768-1774
  • 49 Nami Y, Haghshenas B, Haghshenas M, Abdullah N, Yari Khosroushahi A. The prophylactic effect of probiotic Enterococcus lactis IW5 against different human cancer cells. Front Microbiol 2015; 6: 1317